PressReleases from RealWire


PAREXEL International Corporation is a leading innovator of global biopharmaceutical services. We simplify our clients'' journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world. For more information, visit www.PAREXEL.com. PAREXEL is a registered trademark of PAREXEL International Corporation. All other trademarks are the property of their respective owners. ...


all PressReleases